Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4'-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
2. Dd 3480
1. 57648-21-2
2. Tolopelon
3. Dd-3480
4. 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-2-benzimidazolinethione
5. 626dq7n19l
6. Timiperone (jan)
7. Timiperone [jan]
8. 4-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
9. 1-butanone, 4-(4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl)-1-(4-fluorophenyl)-
10. Timiperona
11. Timiperonum
12. Timiperone [inn:jan]
13. Timiperonum [inn-latin]
14. Timiperona [inn-spanish]
15. 1-butanone, 4-[4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl]-1-(4-fluorophenyl)-
16. Ncgc00182555-01
17. Einecs 260-880-9
18. Dd 3480
19. Unii-626dq7n19l
20. Tolopelon (tn)
21. Timiperone [mi]
22. Timiperone [inn]
23. 4'-fluoro-4-(4-(2-thioxo-1-benzimidazolinyl)piperidino)butyrophenone
24. Butyrophenone, 4'-fluoro-4-(4-(2-thioxobenzimidazol-1-yl)piperidino)-
25. Dsstox_cid_3673
26. 2-benzimidazolinethione, 1-(1-(3-(p-fluorobenzoyl)propyl)-4-piperidyl)-
27. Timiperone [mart.]
28. 1-(4-fluorophenyl)-4-[4-(2-sulfanylidene-3h-benzimidazol-1-yl)piperidin-1-yl]butan-1-one
29. Dsstox_rid_77139
30. Timiperone [who-dd]
31. Dsstox_gsid_23673
32. Schembl145839
33. Chembl2107117
34. Dtxsid9023673
35. Schembl11797177
36. Chebi:135631
37. Zinc3873392
38. Tox21_113628
39. Akos025396887
40. Ncgc00387301-01
41. 4-(4-(2,3-dihydro-2-thioxo-1h-benzimidazol-1-yl)-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone
42. Cas-57648-21-2
43. Ft-0675238
44. D02035
45. 648t212
46. Q7806745
47. 1-[1-(3-(4-fluorobenzoyl)propyl)-4-piperidyl]-2-mercaptobenzimidazole
48. 1-(4-fluorophenyl)-4-[4-(2-thioxo-2,3-dihydro-1h-benzimidazol-1-yl)piperidin-1-yl]butan-1-one
Molecular Weight | 397.5 g/mol |
---|---|
Molecular Formula | C22H24FN3OS |
XLogP3 | 4.3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 6 |
Exact Mass | 397.16241173 g/mol |
Monoisotopic Mass | 397.16241173 g/mol |
Topological Polar Surface Area | 67.7 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 558 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?